- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 265/36 - 1,4-OxazinesHydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
Patent holdings for IPC class C07D 265/36
Total number of patents in this class: 469
10-year publication summary
|
31
|
31
|
37
|
37
|
26
|
20
|
35
|
28
|
28
|
7
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| BASF SE | 21303 |
16 |
| BP Oil International Limited | 71 |
15 |
| Merck Sharp & Dohme LLC | 3734 |
14 |
| Boehringer Ingelheim International GmbH | 4493 |
10 |
| Abbvie Inc. | 1836 |
9 |
| Takeda Pharmaceutical Company Limited | 2712 |
8 |
| Calico Life Sciences LLC | 111 |
8 |
| Enko Chem, Inc. | 20 |
8 |
| F. Hoffmann-La Roche AG | 7837 |
7 |
| Albert Einstein College of Medicine, Inc. | 596 |
7 |
| Reviva Pharmaceuticals, Inc. | 50 |
7 |
| The Regents of the University of California | 20745 |
6 |
| AbbVie Deutschland GmbH & Co. KG | 258 |
6 |
| Arcus Biosciences, Inc. | 164 |
6 |
| AstraZeneca AB | 2814 |
5 |
| Sumitomo Chemical Company, Limited | 9016 |
5 |
| Dana-Farber Cancer Institute, Inc. | 2664 |
5 |
| Lycera Corporation | 31 |
5 |
| Mitsubishi Tanabe Pharma Corporation | 403 |
5 |
| Ono Pharmaceutical Co., Ltd. | 421 |
5 |
| Other owners | 312 |